Evidence map›Paper›PMID 37606598›Full record

ArticleThe Journal of infectious diseases2023

Impact of Cannabis Use on Immune Cell Populations and the Viral Reservoir in People With HIV on Suppressive Antiretroviral Therapy.

Shane D Falcinelli, Alicia D Cooper-Volkheimer, Lesia Semenova, Ethan Wu, Alexander Richardson, Manickam Ashokkumar, David M Margolis, Nancie M Archin, Cynthia D Rudin, David Murdoch and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of infectious diseases, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
3.4field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Weed, sex and influenza.ERJ open research · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Shane D FalcinelliDepartment of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.ORCID 0000-0002-3554-226X
Alicia D Cooper-VolkheimerDepartment of Medicine, Duke University, Durham, North Carolina, USA.
Lesia SemenovaDepartment of Computer Science, Duke University, Durham, North Carolina, USA.
Ethan WuDepartment of Computer Science, Duke University, Durham, North Carolina, USA.
Alexander RichardsonDepartment of Computer Science, Duke University, Durham, North Carolina, USA.
Manickam AshokkumarDepartment of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
David M MargolisDepartment of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Nancie M ArchinDepartment of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Cynthia D RudinDepartment of Computer Science, Duke University, Durham, North Carolina, USA.
David MurdochDepartment of Medicine, Duke University, Durham, North Carolina, USA.
Edward P BrowneDepartment of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.ORCID 0000-0001-9070-7015
Duke University · USUniversity of North Carolina at Chapel Hill · US

Funding

Collaboratory of AIDS Researchers for Eradication (CARE)UM1AI164567 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DAVID M. MARGOLIS · 2021 to 2026
$31.6M
POLYCOMB REPRESSIVE COMLEXE AS KEY REGULATORS OF HIV LATENCY AND TARGETS FOR LATENCY REVERSALR61DA047023 · NIDA · UNIV OF NORTH CAROLINA CHAPEL HILL · PI JAMES, LINDSEY INGERMAN · 2018 to 2020
$2.7M
A machine learning framework for understanding impacts on the HIV latent reservoir size, including drugs of abuseR01DA054994 · NIDA · DUKE UNIVERSITY · PI RUDIN, CYNTHIA · 2021 to 2025
$2.3M
Defining the impact of cannabinoids on the latent HIV reservoir through multi-omic analysisR61DA053599 · NIDA · UNIV OF NORTH CAROLINA CHAPEL HILL · PI BROWNE, EDWARD P · 2021 to 2023
$2.0M
Regulation of HIV Latency by Host Cell Transcriptional and Epigenetic NetworksR01AI143381 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI BROWNE, EDWARD P · 2019 to 2022
$1.6M
Reducing the HIV Reservoir: Next-Generation Latency Reversal Agents and T Cell Population TargetsF30AI145588 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI FALCINELLI, SHANE DAVID · 2019 to 2023
$217k
NIAID NIH HHS F30 AI145588NIAID NIH HHS R01 AI143381NIAID NIH HHS UM1 AI164567NIDA NIH HHS R01 DA054994NIDA NIH HHS R61 DA047023NIDA NIH HHS R61 DA053599NIH HHS
6 · The paper itself

Abstract

backgroundHuman immunodeficiency virus (HIV) infection remains incurable due to the persistence of a viral reservoir despite antiretroviral therapy (ART). Cannabis (CB) use is prevalent amongst people with HIV (PWH), but the impact of CB on the latent HIV reservoir has not been investigated.

methodsPeripheral blood cells from a cohort of PWH who use CB and a matched cohort of PWH who do not use CB on ART were evaluated for expression of maturation/activation markers, HIV-specific T-cell responses, and intact proviral DNA.

resultsCB use was associated with increased abundance of naive T cells, reduced effector T cells, and reduced expression of activation markers. CB use was also associated with reduced levels of exhausted and senescent T cells compared to nonusing controls. HIV-specific T-cell responses were unaffected by CB use. CB use was not associated with intact or total HIV DNA frequency in CD4 T cells.

conclusionsThis analysis is consistent with the hypothesis that CB use reduces activation, exhaustion, and senescence in the T cells of PWH, and does not impair HIV-specific CD8 T-cell responses. Longitudinal and interventional studies with evaluation of CB exposure are needed to fully evaluate the impact of CB use on the HIV reservoir.

Indexed as

CannabisHIV-1HIV InfectionsAnti-Retroviral AgentsCD4-Positive T-LymphocytesDNADNA, ViralHumansViral LoadVirus LatencyAnti-Retroviral AgentsDNADNA, ViralantiretroviralcannabisfunctionHIVimmuneinflammationpersistencereservoirsuppressed

Identifiers

PMID37606598
PMCPMC10681869
OpenAlexW4386047120

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.